Gulam Mohammad et al. 2024. An open-label prospective observational study to evaluate the efficacy and safety of alternate day versus daily dosing of atorvastatin in patients of dyslipidemia. Asian Journal of Medical Sciences. 15, 1 (Jan. 2024), 55–59.